Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CerviPrep for Gemcitabine Delivery in Gynecologic Cancers
NCT00610740Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jul 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Cervical Cancer (CC), endometrial cancer (EC), ovarian cancer, sponsored by Masonic Cancer Center. Started Jul 2006; status: completed.
02
Drugs
gemcitabine
03
Conditions
Cervical Cancer (CC)endometrial cancer (EC)ovarian cancer
Beyond the preview
Go deeper on NCT00610740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610740.